SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015861
Filing Date
2020-08-14
Accepted
2020-08-14 16:22:30
Documents
78
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1242817
2 ex10-17.htm EX-10.17 17966
3 ex10-18.htm EX-10.18 256621
4 ex10-19.htm EX-10.19 17913
5 ex31-1.htm EX-31.1 11220
6 ex31-2.htm EX-31.2 11262
7 ex32-1.htm EX-32.1 8832
8 ex10-19_001.jpg GRAPHIC 3633
  Complete submission text file 0001493152-20-015861.txt   5742438

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE qlgn-20200630.xml EX-101.INS 838005
10 XBRL SCHEMA FILE qlgn-20200630.xsd EX-101.SCH 79417
11 XBRL CALCULATION FILE qlgn-20200630_cal.xml EX-101.CAL 70171
12 XBRL DEFINITION FILE qlgn-20200630_def.xml EX-101.DEF 294680
13 XBRL LABEL FILE qlgn-20200630_lab.xml EX-101.LAB 479153
14 XBRL PRESENTATION FILE qlgn-20200630_pre.xml EX-101.PRE 368366
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 201105433
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences